Beta-Blocker Dose Up-Titration or Addition of Ivabradine in Stable Angina: More is Not Necessarily Better Raymond W. SySaul B. Freedman Editorial 21 September 2011 Pages: 501 - 502
The MAGIC Study and the Gastrointestinal Effects of Low-Dose Aspirin John McNeilAndrew Tonkin Editorial 18 October 2011 Pages: 503 - 504
Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice Yumei YeJinqiao QianYochai Birnbaum OriginalPaper 11 October 2011 Pages: 505 - 515
Abdominal Surgical Incision Induces Remote Preconditioning of Trauma (RPCT) via Activation of Bradykinin Receptors (BK2R) and the Cytochrome P450 Epoxygenase Pathway in Canine Hearts Garrett J. GrossJohn E. BakerKasem Nithipatikom OriginalPaper 26 July 2011 Pages: 517 - 522
Reduction of Cerebral Infarct Size by Dronedarone Tobias EngelhornMarc A. SchwarzRainer Schulz OriginalPaper 01 September 2011 Pages: 523 - 529
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina E. AmosovaE. AndrejevR. Ferrari OriginalPaper 10 August 2011 Pages: 531 - 537
Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome Robert S. RosensonHeather FraserColin Hislop OriginalPaper 12 October 2011 Pages: 539 - 544
C-Reactive Protein, Statins and the Risk of Vascular Events: A Better Understanding Behnood Bikdeli Short Communication 27 July 2011 Pages: 545 - 549
Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study Hideki OrigasaShinya Gotoon behalf of the MAGIC Investigators OriginalPaper 13 August 2011 Pages: 551 - 560
Stroke Prevention in Atrial Fibrillation Jonathan P. PicciniThomas W. WallaceRichard C. Becker ReviewPaper 17 September 2011 Pages: 561 - 570
High Dose Statin Treatment and New Onset Diabetes Juan Carlos Kaski ISCP President’s Page 14 September 2011 Pages: 571 - 572
